SEARCH OUR PRODUCT CATALOG

CTTN-PSME2 Fusion FISH Probe

The CTTN-PSME2 Fusion FISH Probe is used to confirm a fusion of the CTTN and PSME2 genes. The fusion of the CTTN and PSME2 genes has been associated with Breast Invasive Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.

** This product is for in vitro and research use only. This product is not intended for diagnostic use.

Turnaround Time: 7-10 Business Days    Shipping Time: 1-2 Day Expedited Shipping

SKU Test Kits Buffer Dye Color Order Now
CTTN-PSME2-20-ORGR  (Standard Design) 20 (40 μL) 200 μL
CTTN-PSME2-20-RERE 20 (40 μL) 200 μL
CTTN-PSME2-20-REOR 20 (40 μL) 200 μL
CTTN-PSME2-20-REGO 20 (40 μL) 200 μL
CTTN-PSME2-20-REGR 20 (40 μL) 200 μL
CTTN-PSME2-20-REAQ 20 (40 μL) 200 μL
CTTN-PSME2-20-ORRE 20 (40 μL) 200 μL
CTTN-PSME2-20-OROR 20 (40 μL) 200 μL
CTTN-PSME2-20-ORGO 20 (40 μL) 200 μL
CTTN-PSME2-20-ORAQ 20 (40 μL) 200 μL
CTTN-PSME2-20-GORE 20 (40 μL) 200 μL
CTTN-PSME2-20-GOOR 20 (40 μL) 200 μL
CTTN-PSME2-20-GOGO 20 (40 μL) 200 μL
CTTN-PSME2-20-GOGR 20 (40 μL) 200 μL
CTTN-PSME2-20-GOAQ 20 (40 μL) 200 μL
CTTN-PSME2-20-GRRE 20 (40 μL) 200 μL
CTTN-PSME2-20-GROR 20 (40 μL) 200 μL
CTTN-PSME2-20-GRGO 20 (40 μL) 200 μL
CTTN-PSME2-20-GRGR 20 (40 μL) 200 μL
CTTN-PSME2-20-GRAQ 20 (40 μL) 200 μL
CTTN-PSME2-20-AQRE 20 (40 μL) 200 μL
CTTN-PSME2-20-AQOR 20 (40 μL) 200 μL
CTTN-PSME2-20-AQGO 20 (40 μL) 200 μL
CTTN-PSME2-20-AQGR 20 (40 μL) 200 μL
CTTN-PSME2-20-AQAQ 20 (40 μL) 200 μL

CTTN Gene Summary

This gene is overexpressed in breast cancer and squamous cell carcinomas of the head and neck. The encoded protein is localized in the cytoplasm and in areas of the cell-substratum contacts. This gene has two roles: (1) regulating the interactions between components of adherens-type junctions and (2) organizing the cytoskeleton and cell adhesion structures of epithelia and carcinoma cells. During apoptosis, the encoded protein is degraded in a caspase-dependent manner. The aberrant regulation of this gene contributes to tumor cell invasion and metastasis. Three splice variants that encode different isoforms have been identified for this gene. [provided by RefSeq, May 2010]

Gene Name: Cortactin

Chromosome: CHR11: 70244611 -70282690

Locus: 11q13.3

PSME2 Gene Summary

The 26S proteasome is a multicatalytic proteinase complex with a highly ordered structure composed of 2 complexes, a 20S core and a 19S regulator. The 20S core is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. The 19S regulator is composed of a base, which contains 6 ATPase subunits and 2 non-ATPase subunits, and a lid, which contains up to 10 non-ATPase subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. The immunoproteasome contains an alternate regulator, referred to as the 11S regulator or PA28, that replaces the 19S regulator. Three subunits (alpha, beta and gamma) of the 11S regulator have been identified. This gene encodes the beta subunit of the 11S regulator, one of the two 11S subunits that is induced by gamma-interferon. Three beta and three alpha subunits combine to form a heterohexameric ring. Six pseudogenes have been identified on chromosomes 4, 5, 8, 10 and 13. [provided by RefSeq, Jul 2008]

Gene Name: Proteasome Activator Subunit 2

Chromosome: CHR14: 24612573 -24615855

Locus: 14q12

Gene Diseases

The CTTN PSME2 Fusion has been associated with the following diseases:

Disease Name
Breast Invasive Carcinoma

FISH Probe Protocols

Protocol, Procedure, or Form Name Last Modified Download

Customer Publications

There are currently no FISH related publications for this probe.